We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+4.41%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$42.6B
AUM Growth
+$4.82B
Cap. Flow
+$3.68B
Cap. Flow %
8.65%
Top 10 Hldgs %
12.95%
Holding
2,932
New
107
Increased
1,463
Reduced
1,212
Closed
134

Sector Composition

Rank Sector Weight
1 Technology 12.83%
2 Financials 12.17%
3 Healthcare 10.88%
4 Industrials 10.2%
5 Consumer Discretionary 9.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNMX
2776
DELISTED
Senomyx, Inc.
SNMX
$12K ﹤0.01%
19,129
+4,030
+27% +$2.79K
IMI
2777
DELISTED
Intermolecular, Inc.
IMI
$11K ﹤0.01%
10,779
-27
-0.2% -$25
ASTC icon
2778
Astrotech Corp
ASTC
$13.6M
$10K ﹤0.01%
+68
New +$8.42K
GEF.B icon
2779
Greif Class B
GEF.B
$4.11B
$10K ﹤0.01%
172
-4
-2% -$244
ESNC
2780
DELISTED
EnSync Inc
ESNC
$10K ﹤0.01%
20,066
-64
-0.3% -$26
DSS icon
2781
DSS Inc
DSS
$5.35M
$9K ﹤0.01%
19
+1
+6% +$403
SDPI
2782
DELISTED
Superior Drilling Products Inc.
SDPI
$9K ﹤0.01%
+11,129
New +$7.9K
TMBR
2783
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$9K ﹤0.01%
2
OGEN icon
2784
Oragenics
OGEN
$2.39M
$8K ﹤0.01%
1
UAMY icon
2785
United States Antimony
UAMY
$839M
$8K ﹤0.01%
28,415
+2,838
+11% +$938
AUMN
2786
DELISTED
Golden Minerals Company
AUMN
$8K ﹤0.01%
708
+1
+0.1% +$13
GMO
2787
DELISTED
General Moly, Inc.
GMO
$8K ﹤0.01%
22,259
+4,151
+23% +$1.75K
BATRA icon
2788
Atlanta Braves Holdings Series A
BATRA
$3.49B
$7K ﹤0.01%
305
-7
-2% -$173
AGIG
2789
Abundia Global Impact Group
AGIG
$42M
$7K ﹤0.01%
+109
New +$7.58K
SINT icon
2790
SiNtx Technologies
SINT
$11.3M
0
SLS icon
2791
SELLAS Life Sciences
SLS
$2.21B
$7K ﹤0.01%
13
+4
+44% +$2.64K
CRTN
2792
DELISTED
Cartesian, Inc.
CRTN
$7K ﹤0.01%
10,657
+572
+6% +$372
AIM
2793
AIM ImmunoTech
AIM
$7.32M
$7K ﹤0.01%
5
+2
+67% +$3.51K
AVGR
2794
DELISTED
Avinger, Inc. Common Stock
AVGR
0
XTIA icon
2795
XTI Aerospace
XTIA
$57.3M
0
BONT
2796
DELISTED
Bon-Ton Stores Inc/The
BONT
$5K ﹤0.01%
+10,572
New +$6.12K
ARGS
2797
DELISTED
Argos Therapeutics, Inc.
ARGS
$5K ﹤0.01%
+1,399
New +$6.71K
RNVA
2798
DELISTED
Rennova Health, Inc.
RNVA
$3K ﹤0.01%
+1,188
New +$5.08K
ACHV icon
2799
Achieve Life Sciences
ACHV
$649M
-7
Closed -$5K
AEF
2800
abrdn Emerging Markets Equity Income Fund
AEF
$356M
-27,847
Closed -$197K

Similar funds

Guggenheim Capital's Q3 2017 Portfolio in Review

As of Q3 2017, Guggenheim Capital held 2,932 positions worth $42.6B, up 13% from $37.8B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Guggenheim Capital deployed $3.68B of net new capital in Q3 2017, opening 107 new positions and adding to 1,463 existing holdings. Its largest new stake was CLAYMORE US CAPITAL MARKETS MICRO-TERM FIXED INCOME ETF: 1,677,943 shares worth $84.5M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was MALLINCKRODT PUBLIC LIMITED COMPANY, an estimated $46.6M trimmed.

  • Guggenheim Capital's largest Q3 2017 buy was CLAYMORE US CAPITAL MARKETS MICRO-TERM FIXED INCOME ETF: 1,677,943 shares worth $84.5M.
  • Guggenheim Capital added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2017, an estimated $209M increase.
  • Guggenheim Capital's biggest Q3 2017 reduction was MALLINCKRODT PUBLIC LIMITED COMPANY, cutting an estimated $46.6M.
  • Guggenheim Capital fully exited Reynolds American Inc in Q3 2017, selling an estimated $68.3M.
  • Guggenheim Capital's ten largest holdings make up 13% of its $42.6B portfolio in Q3 2017.
  • Guggenheim Capital opened 107 new positions and closed 134 in Q3 2017.
  • Guggenheim Capital's portfolio value rose 13% quarter-over-quarter to $42.6B.

Based on Guggenheim Capital's 13F filing for Q3 2017, filed 14 Nov 2017.